Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review

Hypoactive sexual desire disorder (HSDD) is hypothesised to manifest in postmenopausal women at onset of menopause due to decreased oestrogen levels. Transdermal testosterone is a potential treatment option. This systematic review explores the relationship between the incidence of breast cancer and transdermal testosterone use.Searches were conducted on the PubMed and Ovid databases. In Ovid, the advanced search function was used: 'transdermal...